Phyllis Spieler
Rheumatology · Andover, MANPI 1083870240
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 166 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 12.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $919 and has fallen 91.9% since, to $75 in 2022.
Across 166 payments — averaging $14.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$311
- AbbVie$301
- Novartis$301
- Lilly USA, LLC$293
- GSK$175
- E.r. Squibb & Sons, L.L.C.$129
- plus $947 from 21 others
What the payments were for
- Food & beverage$2,37197%
- Education$843%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 22 | $311 |
| AbbVie(2 entities) | 24 | $301 |
| Novartis | 20 | $301 |
| Lilly USA, LLC | 29 | $293 |
| GSK | 9 | $175 |
| E.r. Squibb & Sons, L.L.C. | 7 | $129 |
| AstraZeneca(2 entities) | 7 | $117 |
| Johnson & Johnson | 3 | $106 |
| UCB, Inc. | 5 | $97 |
| Actelion Pharmaceuticals US, Inc. | 4 | $71 |
| Merck | 4 | $69 |
| Boehringer Ingelheim | 4 | $54 |
| Pfizer | 3 | $53 |
| Mallinckrodt Hospital Products Inc. | 3 | $53 |
| LEO Pharma Inc. | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
| Hikma Pharmaceuticals USA | 3 | $37 |
| Amarin Pharma, Inc. | 2 | $28 |
| Mylan Specialty L.p. | 2 | $28 |
| Sobi, Inc | 2 | $26 |
| Collegium Pharmaceutical, Inc. | 2 | $25 |
| Ironwood Pharmaceuticals, Inc | 2 | $24 |
| Genentech USA, Inc. | 2 | $23 |
| Organon | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Nestle Healthcare Nutrition Inc. | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $11 |
How this compares
$2,455 in reported general payments places this provider in the 65th percentile of 265 rheumatology providers in Massachusetts.
Other rheumatology in Andover
- Marilyn PikeBoston$1.4M
- John StoneBoston$926K
- Lee SimonBoston$600K
- Jeffrey SparksBoston$299K
- Ronald RapoportFall River$293K
- Richard ChouPalmer$270K
- Tanya LaidlawBoston$244K
- Tuhina NeogiBoston$242K
- Michael WeinblattBoston$228K
- Thomas GoodmanGroton$211K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.